Complejo Hospitalario Dr. Arnulfo Arias Madrid Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2013
NCT01988298
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

1. Complejo Hospitalario Metropolitano Arnulfo Arias Madrid, Caja de Seguro Social | Complejo Hospitalario Dr. Arnulfo Arias Madrid

Active Ingredients

Drugs in Phase 3 Trials (3)

acetaminophen (tylenol) (1 trial)

ibuprofen (motrin) (1 trial)

magnesium sulfate (Tis-U-Sol) (2 trials)

Drugs in Phase 1 Trials (1)

COVID-19 convalescent plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eclampsia (Phase 3)

Pre-Eclampsia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4